基线及术后C反应蛋白水平预测可手术肺癌患者死亡率
研究纳入2003至2015年间接受完全切除术的1750例连续肺癌患者,检测基线及术后3天C反应蛋白(CRP)水平,按CRP0和/或CRP3高于相应中位数将患者分为0、1、2个危险因素组。结果显示5年生存率随危险因素增加而降低(67%、58%、41%,P<0.0001),1个危险因素组调整后风险比(aHR)1.43(95%CI 1.14-1.79),2个危险因素组aHR 2.49(95%CI 1.99-3.11)。结论认为基线及术后CRP水平可预测各分期可手术肺癌患者的近期和远期死亡率。
要点
- 可手术肺癌患者中,基线及术后CRP高于中位数的危险因素个数与5年生存率呈负相关。
- 2个危险因素组术后30天死亡率显著高于0个危险因素组(2.2% vs 0.6%,p<0.0475)。
- CRP升高对各TNM分期亚组及非吸烟者亚组的生存均有显著影响。
核心结论
- 基线及术后CRP水平可预测所有分期可手术肺癌患者的近期和远期死亡率。
- CRP水平较高的患者可作为抗炎药物随机辅助试验的候选人群。
研究设计与样本
- 研究为连续纳入1750例2003至2015年间接受完全切除术的肺癌患者,检测基线(CRP0)和术后3天(CRP3)CRP值。
- 按CRP0和/或CRP3高于相应中位数将患者分为0个(N=593)、1个(N=658)或2个(N=553)危险因素组。
- 采用Kaplan-Meier死亡率曲线和Cox比例风险模型计算调整后风险比(aHR)及95%置信区间(CI)。
主要发现
- 5年生存累积比例:0个危险因素组67%,1个危险因素组58%,2个危险因素组41%(P<0.0001)。
- 总体5年死亡风险:1个危险因素组aHR 1.43(95%CI 1.14-1.79),2个危险因素组aHR 2.49(95%CI 1.99-3.11)。
- 术后30天死亡率:2个危险因素组显著高于0个危险因素组(2.2% vs 0.6%,p<0.0475)。
- 各TNM分期组及非吸烟者亚组中均观察到CRP对生存的显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Higher blood levels of C-reactive protein (CRP) have been associated with shorter survival in patients with cardiovascular, chronic obstructive pulmonary disease and cancer. We investigated the impact of baseline and postoperative CRP levels on survival of patients with operable lung cancer (LC). PATIENTS AND METHODS: CRP values at baseline (CRP0) and 3 days after surgery (CRP3) were measured in a consecutive series of 1750 LC patients who underwent complete resection between 2003 and 2015. Patients were classified as having 0 (N = 593), 1 (N = 658) or 2 (N = 553) risk factors: CRP0 and/or CRP3 values above the respective median value. The effect of higher CRP was evaluated by Kaplan-Meier mortality curves and adjusted hazard ratio (HR) with 95% confidence interval (CI), by fitting Cox proportional hazards models. RESULTS: Cumulative proportions of 5-year survival were 67% for 0 risk factors, 58% for 1 risk factor and 41% for 2 risk factors (P < 0.0001). The overall 5-year mortality risk was significantly higher in patients with 1 risk factor (adjusted hazard ratio [aHR] 1.43 [95% CI 1.14-1.79]), or 2 risk factors (aHR 2.49 [95% CI 1.99-3.11]). A significant impact on survival was observed in each tumour-node-metastasis stage group, and in the subset of non-smokers. Postoperative 30-day mortality was significantly higher in patients with 2 risk factors only (aHR 2.2% versus 0.6%, p < 0.0475). CONCLUSIONS: Baseline and postoperative CRP levels predict immediate and long-term mortality in all stages of operable lung cancer. Patients with higher CRP levels could be candidate to randomised adjuvant trials with anti-inflammatory agents.
引用
- Pastorino U, Morelli D, Leuzzi G, et al. Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer. Eur J Cancer. 2017. PMID: 28472743. doi:10.1016/j.ejca.2017.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。